Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Alpha Cancer Technologies (aka ACT) is Profiled in this Database

Updated At 28 Jun, 2012

Start Free 7 Day Trial Now
Partial description of this company
A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Alpha Cancer Technologies (aka ACT) plus 4972 other startups.

Start Free 7 Day Trial Now

Learn More About Alpha Cancer Technologies (aka ACT)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation


Our Clients